CP and Alzheimer disease: GFAP is commonly considered a marker for astrogliosis, and other transcripts associated with gliosis [55–57], including CD44, VIM, OSMR, CP, S1PR3, HSPB1, are elevated in the human AD portrait and matching mouse models, suggesting reactive astrocytes could contribute to the profile.